Home

TaySachs

Tay-Sachs disease is a rare inherited neurodegenerative disorder caused by mutations in the HEXA gene, which lead to a deficiency of the enzyme beta-hexosaminidase A. This enzymatic defect prevents the breakdown of GM2 ganglioside within lysosomes, resulting in GM2 accumulation in neurons and progressive neural damage. The condition is part of a broader group known as GM2 gangliosidoses.

Tay-Sachs is inherited in an autosomal recessive pattern. Carrier frequency is notably higher in certain populations,

The most common form is the infantile variant, with onset typically between 3 and 6 months of

Diagnosis is based on measuring beta-hexosaminidase A activity in blood or leukocytes; a deficient activity suggests

There is no cure for Tay-Sachs disease. Management is supportive and multidisciplinary, focusing on symptom relief

particularly
people
of
Ashkenazi
Jewish
descent,
but
the
disorder
can
occur
in
any
ethnic
group.
Genetic
testing
and
counseling
are
available
for
at-risk
couples
and
for
guiding
prenatal
decisions.
age.
Early
signs
include
developmental
delay,
loss
of
motor
skills,
decreased
muscle
tone
(hypotonia),
exaggerated
startle
responses,
and
poor
visual
tracking.
A
characteristic
cherry-red
spot
at
the
retina
may
be
observed.
Progression
leads
to
seizures,
blindness,
severe
intellectual
and
motor
decline,
and
death
usually
by
age
4.
There
are
also
juvenile
and
adult-onset
forms,
which
have
slower
progression
and
more
variable
symptoms,
including
ataxia,
motor
difficulties,
and
psychiatric
or
neurological
features.
Tay-Sachs
and
can
be
confirmed
with
genetic
testing
for
HEXA
mutations.
Imaging
and
other
tests
may
support
evaluation
of
neurological
involvement.
and
quality
of
life.
Population
screening
programs
and
carrier
testing
have
contributed
to
reducing
incidence
in
high-risk
groups,
complemented
by
genetic
counseling
for
family
planning.
The
disease
was
named
after
Warren
Tay,
who
first
described
the
retinal
cherry-red
spot,
and
Bernard
Sachs,
who
contributed
to
understanding
its
neuropathology,
with
the
genetic
basis
characterized
in
later
decades.